In the high-stakes world of pharmaceuticals, the race doesn’t end at patent expiration — it merely shifts gears. For many companies, the real challenge begins after the patent clock runs out, and the market becomes a battleground for market share, reve…
How to own a Market you Don’t Own: Market Access Strategies Post-Patent Expiration Read Post »
In the fiercely competitive world of pharmaceuticals, understanding your rivals’ strategies isn’t just advantageous—it’s essential. Yet, for many industry insiders, the secret sauce remains elusive, hidden behind layers of patent filings and complex le…
Cracking the Code: Using Drug Patents to Reveal Competitor Formulation Strategies Read Post »
In the rapidly evolving landscape of biopharmaceuticals, the emergence of biosimilars is not just a trend—it’s a strategic pivot that could redefine how companies innovate, protect, and monetize their biologic assets. As the patent cliffs of blockbuste…
In the rapidly evolving landscape of healthcare innovation, the intersection of academic research, policy development, and pharmaceutical patent strategies has never been more critical. Yet, navigating the complex web of drug patents, pricing, and acce…
How Academic Researchers and Policy Experts Use DrugPatentWatch Read Post »
In the high-stakes world of pharmaceuticals, where innovation can mean the difference between life-changing therapies and missed opportunities, the way companies approach patent strategy can make or break their success. Yet, surprisingly, many organiza…
Unlocking the Future of Generic Drugs: Overcoming Formulation Challenges in Development
In the rapidly evolving landscape of pharmaceuticals, the race to bring affordable, effective generic drugs to market is more competitive—and more complex—than ever…
Overcoming Formulation Challenges in Generic Drug Development Read Post »
In the fiercely competitive world of pharmaceuticals, gaining a foothold in the market isn’t just about developing a groundbreaking drug—it’s about mastering the art of strategic manufacturing and pricing. A recent deep dive by Drug Patent Watch sheds …
"The Unseen Heroes of the Pharmaceutical Industry: How Generic Manufacturers Are Revolutionizing Access to Affordable Medications
As the cost of prescription medications continues to skyrocket, one often-overlooked group is playing a crucial role …
The Role of Generic Drug Manufacturers in Patent Disputes Read Post »
The Expiration Date Countdown: How Pharma Executives Can Turn Patent Cliff Risks into Strategic Opportunities
As the pharmaceutical industry navigates a rapidly changing landscape, one constant remains: the patent expiration calendar. For pharma execut…
Patent Expiration Calendar: Strategic Planning Guide for Pharma Executives Read Post »
In the rapidly evolving landscape of drug discovery, artificial intelligence (AI) is no longer just a futuristic concept—it’s a transformative force reshaping how we develop new medicines. But as AI accelerates innovation, a pressing question emerges: …
AI Meets Drug Discovery – But Who Gets the Patent? Read Post »
Get new actionable insights and updates from BiotechBlog
